W
WLC

Topic

FDA-regulation

2 articles on fda-regulation in longevity medicine. View all news →

Ars Technica: RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Peer-reviewed

Peptide Therapy at Longevity Clinics: What's Legal, What Works & What's Next (2026)

Peptide therapy is the fastest-growing treatment category at longevity clinics. But RFK Jr.'s push to reclassify 12 banned peptides has created confusion. Here's which peptides clinics actually use, what the evidence says, what they cost, and how to choose a clinic.

NPR: The government may soon lift restrictions on some peptide treatments Peer-reviewed

FDA Peptide Reclassification 2026: What It Means for Longevity Clinics and Patients

HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.